Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Elizabeth A. Sillman
Observed name:
E. Sillman
Institution:
Insight Therapeutics
Observed institution:
Insight Therapeutics
ORCID:
0009-0004-0140-539X
Observed ORCID:
0009-0004-0140-539X
OpenAlex ID:
A5117509009
Assessing feasibility of real‑world respiratory virus syndromic surveillance in nursing homes using point‑of‑care molecular testing
2026
·
Lisa F. Han
, Ivis Perez
, et al.
·
Infection Control and Hospital Epidemiology
PDF
Invasive E. coli Disease in US Nursing Homes: Brief Report of Case Validation Findings
2026
·
H. Edward Davidson
, Lisa F. Han
, et al.
·
Journal of the American Geriatrics Society
Respiratory surveillance through point of care molecular testing and its impacts on nursing home RSV, influenza, and SARS-CoV-2 awareness and reporting behavior: a pilot study.
2026
·
H. Edward Davidson
, Lisa F. Han
, et al.
·
Antimicrobial Stewardship & Healthcare Epidemiology
PDF
Bridging the Gap in RSV Detection: Nursing Home Respiratory Pathogen Detection and Reporting With Enhanced Surveillance
2025
·
Y. Abul
, E. Davidson
, et al.
·
American Journal of Respiratory and Critical Care Medicine
Show more works
View as search
Works count:
4
Citation count:
H-index:
I10-index:
Year
Topic
Type
